Opinion
Video
Recent Medical Advancements: Opportunities and Considerations
Author(s):
An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.
Video Player is loading.
Related Videos
Adjunctive Treatments and Apomorphine for Treatment of Parkinson Disease
Advanced Treatment Options in Parkinson Disease
Personalizing Treatment Plans for Patients With PD
ARIA With Monoclonal Antibody Treatments for Alzheimer Disease
Lecanemab for Treatment of Early Alzheimer Disease
Patient Insights and Evolving Treatment Combos in PD
Technological Advances Leading the Future of Parkinson Care: Cheryl Kyinn, PA-C
The Growing Role of AI in Neurology
Continuous Subcutaneous Delivery Systems: Foscarbidopa/Foslevodopa for Treatment of Parkinson Disease
Improving CSAI Adherence and Its Evolving Role in PD
Related Content
